country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-114721

Copy Link Print Information

BTA-9881

Name: BTA-9881
Brand: MedChemExpress
SKU: HY-114721
Price: 192.00 USD
Availability: InStock
Rating: 5 (1 reviews)

(Synonyms: MEDI-564)

BTA-9881 (MEDI-564) is a RSV inhibitor, with an EC₅₀: 48 nM, 59 nM and 160 nM for RSV A2, RSV Long, and RSV B1. BTA-9881 has favorable pharmacokinetics property.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 1646857-24-0
Formel: C₂₁H₁₅ClN₄O₂
Molecular Weight:390.82

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (278 KB)

BTA-9881 Chemical Structure

CAS. Nr.: 1646857-24-0

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
- Clinical Trial
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

BTA-9881 (MEDI-564) is a RSV inhibitor, with an EC₅₀: 48 nM, 59 nM and 160 nM for RSV A2, RSV Long, and RSV B1. BTA-9881 has favorable pharmacokinetics property^[1].

Cellular Effect

Cell Line	Type	Value	Description	References
HEp-2	EC₅₀	0.048 μM Compound: 33a	Antiviral activity against respiratory syncytial virus A2 infected in human Hep2 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay Antiviral activity against respiratory syncytial virus A2 infected in human Hep2 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay	[PMID: 25595685]
HEp-2	EC₅₀	0.059 μM Compound: 33a	Antiviral activity against respiratory syncytial virus Long infected in human Hep2 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay Antiviral activity against respiratory syncytial virus Long infected in human Hep2 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay	[PMID: 25595685]
HEp-2	EC₅₀	0.16 μM Compound: 33a	Antiviral activity against respiratory syncytial virus B1 infected in human Hep2 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay Antiviral activity against respiratory syncytial virus B1 infected in human Hep2 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay	[PMID: 25595685]

Clinical Trial

NCT Number	Sponsor	Condition	Start Date	Phase A549
NCT01329991	Plexxikon\|		2011-05	PHASE1

Chemical Information

CAS. Nr. 1646857-24-0
Molecular Weight 390.82
Formel C₂₁H₁₅ClN₄O₂
SMILES

O=C1N2[C@@](C3=CC=C(C=C3)Cl)(N(CC2)C(C4=CC=CN=C4)=O)C5=C1C=CN=C5
Synonyms

MEDI-564
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (278 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Bond S, et al. 1,2,3,9b-Tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: identification of BTA9881 as a preclinical candidate. Bioorg Med Chem Lett. 2015 Feb 15;25(4):976-81. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen